Thyrocare Recognized with National Diagnostics Forum Awards

Thyrocare Technologies Limited has been honored with two awards at the 4th Edition of the National Diagnostics Forum & Awards 2026. The awards include the Best Diagnostic Lab Chain of the Year and Patient-Centric Diagnostic Company of the Year. This recognition highlights Thyrocare’s commitment to quality, affordability, and patient-focused diagnostic services.

Prestigious Recognition

Thyrocare Technologies Limited has received significant recognition at the 4th Edition of the National Diagnostics Forum & Awards 2026, held on January 21, 2026, in Mumbai. The company was awarded in two prominent categories, solidifying its position in the diagnostics industry.

Award Details

The awards conferred upon Thyrocare are:

  • Best Diagnostic Lab Chain of the Year
  • Patient-Centric Diagnostic Company of the Year

Commitment to Excellence

These awards reflect Thyrocare’s mission to ensure accessible, high-quality, and affordable diagnostic services. The company’s focus remains on patient-centric care, innovation, and operational excellence, driving its success and recognition in the healthcare sector.

Source: BSE

Previous Article

Zensar Technologies Board Approves Interim Dividend & Financial Results

Next Article

Zensar Technologies Registers 2.2% YoY Revenue Growth in Q3 FY26